Status:
COMPLETED
COVID-19 Among Children With Chronic Renal Diseases in Qatar
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Chronic Kidney Diseases
COVID-19 Infection
Eligibility:
All Genders
Up to 18 years
Brief Summary
Coronavirus disease 2019 is a novel viral disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 virus. The original cases occurred in Wuhan, China, in December 2019 and rapidly spread ...
Detailed Description
In this retrospective study investigators will include all children and adolescents (≤ 18 years old) with pre-existing CKD and laboratory-confirmed SARS-CoV-2 infection who were treated at Hamad Gener...
Eligibility Criteria
Inclusion
- All children and adolescents (≤ 18 years old).
- who have underlying kidney disease.
- laboratory-confirmed SARS-CoV-2 infection.
Exclusion
- Patients with SARS-CoV-2 infection who developed AKI during the hospital stay but lacked evidence of pre-existing kidney disease.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT05275595
Start Date
March 1 2022
End Date
December 31 2022
Last Update
July 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Qatar, 3050